Slfn3 inhibitors are a specialized class of chemical compounds designed to target and inhibit the function of the Schlafen family member 3 (Slfn3) protein. Slfn3 is part of the Schlafen (Slfn) family of proteins, which are involved in the regulation of various cellular processes, including cell differentiation, proliferation, and immune responses. Slfn3, in particular, has been implicated in the modulation of cell growth and the regulation of gene expression. By inhibiting Slfn3, researchers can study the effects of disrupted Slfn3 activity on these cellular processes, providing insights into the protein's role in cellular regulation and its broader implications in biological research.
The use of Slfn3 inhibitors in scientific studies allows for a deeper understanding of the molecular pathways influenced by this protein. Researchers utilize these inhibitors to investigate how Slfn3 impacts cell signaling pathways, gene transcription, and the cellular response to environmental stimuli. Inhibition of Slfn3 can lead to changes in the expression of downstream target genes, offering valuable information on the regulatory networks in which Slfn3 is involved. Additionally, Slfn3 inhibitors serve as tools to explore the interactions between Slfn3 and other proteins within the cell, shedding light on the protein's role in maintaining cellular homeostasis. By dissecting these pathways, scientists can gain a better understanding of the complex mechanisms that govern cell behavior and the intricate balance of cellular functions influenced by Slfn3 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus forms a complex with FKBP12 that inhibits mTOR, a kinase involved in protein synthesis, possibly reducing Schlafen (SLFN) family expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, which could indirectly reduce Schlafen (SLFN) family expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, potentially impacting proteins involved in Schlafen (SLFN) family regulation. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and preferentially inhibits transcription of GC-rich templates, which may include the Schlafen (SLFN) family gene. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits Topoisomerase I, leading to DNA damage and potentially affecting Schlafen (SLFN) family transcription. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C cross-links DNA upon reductive activation, which could hinder Schlafen (SLFN) family gene transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits transcription elongation by RNA polymerase, which could reduce Schlafen (SLFN) family mRNA synthesis. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases and might affect cell cycle-related expression of Schlafen (SLFN) family. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that may alter transcription factor activity, possibly reducing Schlafen (SLFN) family expression. | ||||||